Prevalence of TDRM in patients diagnosed from 2002 through 2007.

Algirdas Griskevicius (550418); Ana Abecasis (544734); Anders Sönnerborg (153581); Andrzej Horban (4930); Anne-Mieke Vandamme (7884); Annemarie Wensing31* on behalf of the SPREAD Programme (550426); Birgitta Åsjö (550417); Bonaventura Clotet (91238); Charles Boucher (550425); Claudia Balotta (146815); Claudia Kücherer (51153); Claus Nielsen (856); Colm Bergin (277802); Dan Otelea (374091); Danail Beshkov (391495); Danica Stanekova (550423); Daniel Struck (238450); David van de Vijver (374094); Dimitrios Paraskevis (255852); Dineke Frentz (363422); Elisabeth Puchhammer-Stöckl (475594); Jan Albert (176517); Jean-Claude Schmit (80737); Jurgen Vercauteren (364296); Kirsi Liitsola Marek Linka (550422); Klaus Korn (550420); Leondios Kostrikis (550421); Louise Jørgensen (550416); Maja Stanojevic (550424); Mario Poljak (212447); Osamah Hamouda (51159); Ricardo Camacho (7890); Roger Paredes (180297); Tatjana Kolupajeva (550419); Zehava Grossman (7882)

Prevalence of TDRM in patients diagnosed from 2002 through 2007.

Authors: Algirdas Griskevicius (550418)
Ana Abecasis (544734)
Anders Sönnerborg (153581)
Andrzej Horban (4930)
Anne-Mieke Vandamme (7884)
Annemarie Wensing31* on behalf of the SPREAD Programme (550426)
Birgitta Åsjö (550417)
Bonaventura Clotet (91238)
Charles Boucher (550425)
Claudia Balotta (146815)
Claudia Kücherer (51153)
Claus Nielsen (856)
Colm Bergin (277802)
Dan Otelea (374091)
Danail Beshkov (391495)
Danica Stanekova (550423)
Daniel Struck (238450)
David van de Vijver (374094)
Dimitrios Paraskevis (255852)
Dineke Frentz (363422)
Elisabeth Puchhammer-Stöckl (475594)
Jan Albert (176517)
Jean-Claude Schmit (80737)
Jurgen Vercauteren (364296)
Kirsi Liitsola Marek Linka (550422)
Klaus Korn (550420)
Leondios Kostrikis (550421)
Louise Jørgensen (550416)
Maja Stanojevic (550424)
Mario Poljak (212447)
Osamah Hamouda (51159)
Ricardo Camacho (7890)
Roger Paredes (180297)
Tatjana Kolupajeva (550419)
Zehava Grossman (7882)
Publication date
Publisher
Doi

Abstract

Prevalence of TDRM is shown for any of the drug classes (any class), nucleoside reverse transcriptase inhibitor (NRTI), non-nucleoside reverse transcriptase inhibitor (NNRTI) and protease inhibitor (PI) in (A) Men having sex with men (MSM), and in (B) heterosexuals (HSX). The p-values of the time trends are shown on the right side of the graph.</p

Similar works

Full text

Available Versions

The Francis Crick Institute

oai:figshare.com:article/99570...

Last time updated on 12/02/2018